How is Wolff‑Parkinson‑White (WPW) syndrome diagnosed and managed?

Wolff-Parkinson-White Syndrome: Diagnosis and Management

Diagnosis

WPW syndrome is diagnosed by the presence of ventricular pre-excitation on ECG combined with symptomatic tachyarrhythmias. 1, 2

ECG Criteria for WPW Pattern

The diagnostic ECG features include: 3

• PR interval <120 ms (shortened PR interval)
• Delta wave (slurring of the initial QRS segment)
• QRS duration >120 ms (widened QRS complex)
• Secondary ST-T wave changes that are discordant (opposite direction) to the delta wave and QRS complex

Risk Stratification

High-risk features that predict sudden cardiac death include: 4, 5

• Shortest pre-excited R-R interval <250 ms during atrial fibrillation
• History of symptomatic tachycardia or syncope
• Multiple accessory pathways
• Ebstein's anomaly

The 10-year risk of sudden cardiac death ranges from 0.15% to 0.24%, with highest risk in the first two decades of life. 5

Intermittent pre-excitation (abrupt loss of delta wave with QRS normalization) indicates a longer accessory pathway refractory period and lower risk. 6

Management Approach

Symptomatic Patients with WPW Syndrome

Catheter ablation of the accessory pathway is the definitive treatment for symptomatic patients with WPW syndrome, particularly those with syncope, rapid heart rate, or short bypass tract refractory period. 7, 8

This Class I recommendation (Level of Evidence B) applies to all symptomatic patients, as ablation has high success rates and addresses the underlying substrate. 4, 5

Acute Management of Orthodromic AVRT (Narrow Complex)

For hemodynamically stable patients: 5

1. Vagal maneuvers (Valsalva, carotid sinus massage) - first-line intervention
2. Adenosine IV - if vagal maneuvers fail
3. Synchronized cardioversion - if pharmacological therapy ineffective or contraindicated

For hemodynamically unstable patients: 5

• Immediate synchronized cardioversion is mandatory

Acute Management of Pre-Excited Atrial Fibrillation (Wide Complex)

This is a medical emergency requiring immediate recognition to prevent ventricular fibrillation. 4, 9

For hemodynamically unstable patients: 8

• Immediate direct-current cardioversion to prevent ventricular fibrillation (Class I, Level B)

For hemodynamically stable patients with wide QRS (≥120 ms): 8

• IV procainamide (first-line pharmacologic agent)
• IV ibutilide (alternative agent)
• IV flecainide (Class IIa recommendation)

Critical Contraindications in Pre-Excited AF

NEVER administer the following agents in patients with WPW and pre-excited ventricular activation during AF: 7, 8, 4, 8

• Digoxin
• Diltiazem
• Verapamil
• Beta-blockers (IV administration)
• Adenosine (when QRS ≥120 ms)

These AV nodal blocking agents can increase refractoriness of the AV node, encouraging preferential conduction over the accessory pathway, potentially precipitating ventricular fibrillation. 4

Asymptomatic Pre-Excitation

For asymptomatic patients with WPW pattern on ECG, invasive electrophysiological study should be considered for risk stratification, with catheter ablation offered to those deemed high-risk. 10

The evidence suggests that among asymptomatic patients who underwent ablation versus those who did not, the relative risk reduction for arrhythmic events was 0.08 (92% reduction). 10 However, this must be balanced against the approximately 2% risk of major complications from catheter ablation. 10

Long-Term Management

Following successful catheter ablation: 4

• Ablation eliminates the accessory pathway but may not prevent AF occurrence, especially in older patients
• Additional pharmacological therapy may be required for AF prevention
• Patients can expect normal life expectancy and quality of life with appropriate treatment 11

Common Pitfalls

Misdiagnosing pre-excited AF as ventricular tachycardia and administering AV nodal blockers can be fatal. 9 Always consider WPW in any wide-complex tachycardia with irregular rhythm and extremely rapid rates (>200 bpm). 9

Using adenosine in wide-complex pre-excited tachycardia may precipitate AF with rapid ventricular response. 6 Adenosine should only be used when QRS is narrow (<120 ms), indicating anterograde conduction through the AV node. 4